Johannes Rudolph
About Johannes Rudolph
Johannes Rudolph is a Senior Instructor and Research Associate at the University of Colorado, specializing in enzymology. He holds a Bachelor of Science in Chemistry from the University of Washington and a Ph.D. in Biochemistry from the Massachusetts Institute of Technology.
Work at University of Colorado
Johannes Rudolph has been employed at the University of Colorado since 2007, serving as a Senior Instructor and Research Associate. In this role, he teaches both undergraduate and graduate courses in biochemistry. His teaching responsibilities encompass a range of topics within the discipline, reflecting his extensive background in the field. Additionally, he engages in laboratory research focused on enzymology, contributing to the academic and scientific community at the university.
Education and Expertise
Johannes Rudolph holds a Bachelor of Science (BS) in Chemistry from the University of Washington, where he studied from 1983 to 1988. He further advanced his education by obtaining a Doctor of Philosophy (Ph.D.) in Biochemistry from the Massachusetts Institute of Technology, completing his studies from 1988 to 1993. His academic background provides a solid foundation for his specialization in enzymology within the field of biochemistry.
Previous Experience at Duke University Medical Center
Before his tenure at the University of Colorado, Johannes Rudolph worked at Duke University Medical Center as an Assistant Professor from 1999 to 2006. During this period, he contributed to both teaching and research in biochemistry, gaining valuable experience that informs his current work. His time at Duke University Medical Center helped shape his approach to education and research in the field.
Professional Role at Array BioPharma
Johannes Rudolph briefly worked as a Senior Scientist at Array BioPharma from 2007 to 2008. In this role, he applied his expertise in biochemistry and enzymology within a pharmaceutical context. This experience allowed him to engage with industry practices and contribute to research initiatives in drug development.